Home
ADAR1 Capital Management, 10% Owner: Keros Therapeutics KROS Buy · Filed 25/04/11
Trade details
- Type
- Insider buy
- Amount
- $153,831
- Shares · price
- 16,365 sh · $9.40 a share
- Held after
- 743,558 sh
- Trade date
- 25/04/09
- Filed
- 25/04/11
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 4 insiders
- Holding change
- +2.3%
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/10~25/05/09ADAR1 Capital Management's recent trades
- ADAR1 Capital Management
BuyInMed Pharmaceuticals
BuyInMed Pharmaceuticals
INM
$312K
200,000 sh
$312K
Filed 05/21
Traded 05/19
- ADAR1 Capital Management
BuyInMed Pharmaceuticals
BuyInMed Pharmaceuticals
INM
$300K
200,000 sh
$300K
Filed 05/21
Traded 05/19
- ADAR1 Capital Management
BuyInMed Pharmaceuticals
BuyInMed Pharmaceuticals
INM
$109.7K
68,551 sh
$109.7K
Filed 05/21
Traded 05/19
- ADAR1 Capital Management
BuyRallybio
BuyRallybio
RLYB
$139.8K
10,000 sh
$139.8K
Filed 05/20
Traded 05/19
- ADAR1 Capital Management
BuyRallybio
BuyRallybio
RLYB
$84K
6,009 sh
$84K
Filed 05/20
Traded 05/18
